Human Mesenchymal Stem Cells Reduce Lung Injury in Immunocompromised Mice but Not in Immunocompetent Mice
RespirationPeer ReviewedRebecca Lim +52012Journals
The immunomodulatory and immunosuppressive capacity of human mesenchymal stem cells (hMSC) is well recognized, but efficacies of hMSC in immunocompetent and immunocompromised animals have never been directly compared.
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support